WNT7A and hyperplasia: Wnt7a expression was lower in endometrial carcinomas (26/70, 37.1%) compared with that in normal endometrium (31/35, 88.6%) and hyperplastic endometrium (26/33, 78.8%) (P < 0.001 and P < 0.001, resp).